Abstract
Background
The recent rapid increase of mass screening for prostate cancer by measuring PSA in Japan will increase the economic burden to the healthcare system. PSA Rapid Test (PRT) is a simple inexpensive test. The usefulness of PRT as a primary screening test for prostate cancer was evaluated.
Methods
When we conducted educational lectures for prostate cancer in our city, screening for prostate cancer using PRT was offered to the male participants. The results of the tests were handed to participants in writing at the end of the lectures. When the results were judged as positive, letters of referral to our institute were enclosed.
Results
One hundred and fourteen (18.6%) of 614 men were judged as positive by PRT. Of the 114 men with positive PRT, 73 (64%) visited our institution. Finally, 37 men underwent a transrectal prostate biopsy and a diagnosis of prostate cancer was made in 21 men (3.4% of all participants). The total costs for the PSA tests in this study were summed to be approximately $2,300, while they would be approximately $9,200 if all participants had undergone screening using the conventional quantitative method from the outset.
Conclusion
PRT is a low-cost method to detect patients with prostate cancer. We believe the PRT is useful as an initial screening test for detecting prostate cancer and that the combination of the PRT and more precise quantitative testing would be a reasonable way to reduce the cost and achieve high detection rate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Statistics and Information Department, M.o.L., Health and Welfare: Vital population Statistics in Heisei 15 (2003) in Japan. Table 5-24. Mortality and mortality rate per 100,000 from the standpoint of the etiology, http://www.dbtk.mhlw.go.jp/toukei/data/010/2003/toukeihyou/0004652/t0098908/mc240_001.html
Catalona WJ, Richie JP, Ahmann FR, et al (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151(5):1283–1290
Rietbergen JB, Kranse R, Kirkels WJ, et al (1997) Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection. Br J Urol 79(Suppl 2):57–63
Kobayashi M, Takezawa Y, Nakata S, et al (2000) The result of mass screening of 1997 for prostatic cancer in Isesaki City. Nippon Hinyokika Gakkai Zasshi 91(1):1–7
Kanayama HO, Kagawa S, Utsunomiya M, et al (2004) Mass screening for prostate cancer in Tokushima City: the results of 2001. Nippon Hinyokika Gakkai Zasshi 95(3):596–603
Uchida K, Takeshima H, Akaza H, et al (2000) Screening for prostate cancer using prostate-specific antigen alone as a first-line checkup parameter: results of the health checkup system. Jpn J Clin Oncol 30(2):95–100
Ito K, Kubota Y, Banzai R, Yuasa H, Shimizu N, Kurokawa K, et al (1999) The present status, problems, and future of mass screening for prostate cancer in Gunma prefecture. The report of mass screening for prostate cancer study meeting in 1998. Kitakanto Med J 49:81–88
Stephan C, Jung K, Brux B, et al (2000) ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation. Urology 55(4):560–563
Brawer MK (2000) Prostate-specific antigen. Semin Surg Oncol 18(1):3–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shigeno, K., Arichi, N., Yoneda, T. et al. Usefulness of an immunochromatographical assay, PSA Rapid Test as a primary screening test for prostate cancer. Int Urol Nephrol 38, 565–569 (2006). https://doi.org/10.1007/s11255-006-0086-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-006-0086-2